GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Discover a study validating a disease-specific quality-of-life tool for hidradenitis suppurativa, confirming its reliability, ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Finally, it’s also important to pay attention to your mental health when you have hidradenitis suppurativa; people with HS have a higher risk of depression, anxiety, and low self-esteem.

A new study published in the Journal of American Medical Association showed that new-onset anxiety and sadness were more likely to occur in hidradenitis suppurativa (HS) patients. Although there ...

Hidradenitis suppurativa generally causes inflamed, discolored, swollen bumps that can fill with pus and break open. Sometimes, the condition can also cause scarring and tunneling under your skin.